Abstract
Severe asthma is a complex heterogeneous disease with substantial unmet clinical need. Understanding the immunopathogenesis is likely to provide insights into potential novel therapies. To date researchers have focussed primarily at a single scale for example genome, cell or whole organ physiology. In this review we shall summarise the current knowledge of the immunopathogenesis of severe asthma integrated across multiple scales to provide the insights into the structure function relationships required to begin to unravel the complexity of severe asthma.
Keywords: Asthma, eosinophils, mast cels, remodelling, phenotyping, physiology, immunopathogenesis, Lung, biomechanical, Epidermal growth, neutrophils, cytokines, Mesenchymal progenitors, fibrocytes, hyper-responsiveness, sub-phenotypes
Current Pharmaceutical Design
Title: Immunopathogenesis of Severe Asthma
Volume: 17 Issue: 7
Author(s): Christopher E. Brightling, Sumit Gupta, Fay Hollins, Amanda Sutcliffe and Yassine Amrani
Affiliation:
Keywords: Asthma, eosinophils, mast cels, remodelling, phenotyping, physiology, immunopathogenesis, Lung, biomechanical, Epidermal growth, neutrophils, cytokines, Mesenchymal progenitors, fibrocytes, hyper-responsiveness, sub-phenotypes
Abstract: Severe asthma is a complex heterogeneous disease with substantial unmet clinical need. Understanding the immunopathogenesis is likely to provide insights into potential novel therapies. To date researchers have focussed primarily at a single scale for example genome, cell or whole organ physiology. In this review we shall summarise the current knowledge of the immunopathogenesis of severe asthma integrated across multiple scales to provide the insights into the structure function relationships required to begin to unravel the complexity of severe asthma.
Export Options
About this article
Cite this article as:
E. Brightling Christopher, Gupta Sumit, Hollins Fay, Sutcliffe Amanda and Amrani Yassine, Immunopathogenesis of Severe Asthma, Current Pharmaceutical Design 2011; 17 (7) . https://dx.doi.org/10.2174/138161211795429028
DOI https://dx.doi.org/10.2174/138161211795429028 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Myeloperoxidase: The Good, the Bad, and the Ugly
Current Immunology Reviews (Discontinued) Non-IgE Mediated Food Allergy
Inflammation & Allergy - Drug Targets (Discontinued) The Mast Cell Pathway to Inflammation and Homeostasis: Pharmacolo- gical Insights
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Synthetic Glucocorticoids: Antenatal Administration and Long-term Implications
Current Pharmaceutical Design Mobile Phone Text Message Interventions in Psychiatry - What are the Possibilities?
Current Psychiatry Reviews Silybin and Silymarin - New and Emerging Applications in Medicine
Current Medicinal Chemistry Treatment of Disorders Characterized by Reversible Airway Obstruction in Childhood: are Anti-cholinergic Agents the Answer?
Current Pharmaceutical Design Role of Iron Deficiency and Overload in the Pathogenesis of Diabetes and Diabetic Complications
Current Medicinal Chemistry Oxidative DNA Damage and Oxidant/Anti-Oxidant Enzymatic Systems in Carcinogenesis and Cancer Progression
Current Enzyme Inhibition Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer’s Disease
Current Neuropharmacology Bioactive Peptides in Preventative Healthcare: An Overview of Bioactivities and Suggested Methods to Assess Potential Applications
Current Pharmaceutical Design B Cell Modulation Strategies in Autoimmunity: The SLE Example
Current Pharmaceutical Design Anti-Inflammatory Activity of Human Lens Crystallin Derived Peptide
Current Drug Delivery Cyclic Nucleotide Phosphodiesterases (PDE) and Peptide Motifs
Current Pharmaceutical Design Clinical Pharmacogenetics and Potential Application in Personalized Medicine
Current Drug Metabolism Should we Target Allergen Protease Activity to Decrease the Burden of Allergic Airway Inflammation?
Inflammation & Allergy - Drug Targets (Discontinued) Towards Isozyme-Selective HDAC Inhibitors For Interrogating Disease
Current Topics in Medicinal Chemistry Nutritional Aspects Relating to the Developmental Origins of Health and Disease
Current Women`s Health Reviews Chromones and their Derivatives as Radical Scavengers: A Remedy for Cell Impairment
Current Topics in Medicinal Chemistry 5-Lipoxygenase, Leukotrienes Biosynthesis and Potential Antileukotrienic Agents
Current Medicinal Chemistry